Tumour Functional Heterogeneity Group
Dr Marco Bezzi's group uses genome editing technologies, mouse models, organoid cultures and mass cytometry-based single cell approaches to experimentally model the cancer ecosystem and to investigate how tumour heterogeneity can be controlled and exploited in light of evolution.